Gilead Sciences Inc (NASDAQ:GILD)

63.88
BATS BZX Real-Time Price
As of 1:12pm ET
 +0.44 / +0.69%
Today’s Change
60.32
Today|||52-Week Range
79.61
+2.13%
Year-to-Date

Today’s Trading

Previous close63.44
Today’s open64.01
Day’s range63.68 - 64.25
Volume2,035,439
Average volume (3 months)6,455,476
Market cap$80.1B
Data as of 1:12pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)+18.72%
Earnings growth (this year)+4.98%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-15.00%
P/E ratio13.8
Price/Sales3.68
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+1.11+0.48%
ILMNIllumina Inc+4.88+1.71%
AMGNAmgen+1.35+0.66%
EXASExact Sciences Corp+0.81+0.68%
Data as of 1:12pm ET, 08/21/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$1.75
Annual revenue (last year)$22.2B
Annual profit (last year)$5.5B
Net profit margin24.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Daniel O'Day
CFO, Chief Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts